plerixafor has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertran, E; Caja, L; Fabra, A; Fabregat, I; Mainez, J; Murillo, MM; Navarro, E; Sancho, P; Vinyals, A | 1 |
| Chen, X; Farber, JM; Jacobson, O; Jacobus, JP; Kiesewetter, DO; Szajek, LP; Weiss, ID | 1 |
2 other study(ies) available for plerixafor and Experimental Hepatoma
| Article | Year |
|---|---|
Role of CXCR4/SDF-1 alpha in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-beta.
Topics: Animals; Apoptosis; Benzylamines; Cell Differentiation; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Gene Knockdown Techniques; Heterocyclic Compounds; Liver Neoplasms, Experimental; Mesoderm; NF-kappa B; Phenotype; Rats; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta | 2009 |
Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
Topics: Animals; Benzylamines; Carcinoma, Lewis Lung; Cell Line, Tumor; CHO Cells; Copper Radioisotopes; Cricetinae; Cricetulus; Cyclams; Female; Heterocyclic Compounds; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Imaging; Neoplasms, Experimental; Ovarian Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, CXCR4; Tissue Distribution; Transfection; Transplantation, Heterologous | 2012 |